Biology & biomedicine Technological offers
How to stimulate lymphocytes against cancer
- Details
- Category: Technological offers
-
15 May 2011
The antioxidant enzyme SOD-3 (superoxide dismutase-3), which is produced in the human cell membrane, can help the immune system to eliminate tumour cells, as scientists found out. The discovery suggests new strategies to fight cancer.
Silencing a gene makes a plant resistant to several viral diseases
- Details
- Category: Technological offers
-
01 Feb 2011
CSIC scientists at the the Centro de Edafología y Biología Aplicada del Segura (CEBAS) have developed a method to generate varieties of cucurbits (which includes species such as melon, cucumber, watermelon or pumpkins) resistant to several viral diseases. The method is based on silencing a gene of the plant wich expresses a protein used by the virus for its own replication and spreading of the infection. No foreign elements are introduced, which reduces the chance of unexpected repercussions.
Contact:
Vicepresidencia Adjunta
de Transferencia del Conocimiento /CEBAS - CSIC
Yolanda Hernando
Tel. +(34) 968 39 63 56
This email address is being protected from spambots. You need JavaScript enabled to view it.
Neuroprotective molecules to treat Alzheimer and Parkinson
- Details
- Category: Technological offers
-
24 Nov 2010
Researchers from the CSIC and two spanish universities have developed new propargylamine derivatives for the treatment of neurodegenerative diseases, particularly Alzheimer's.
Derivates of resveratrol to treat inflammatory bowel disease
- Details
- Category: Technological offers
-
02 Dec 2010
Scientists from the CSIC have designed a group of anti-inflammatory compounds, derivates of resveratrol, which have been patented. An experiment to test the new molecules against ulcerative colitis has shown that they are effective in very small quantities.
Modified cells from patient to treat ischemia
- Details
- Category: Technological offers
-
26 May 2010
A group of researchers from the CSIC has developed a new cell therapy that could treat ischemia and renal failure.
